DKK1 and prostate carcinoma: In xenograft models of cancers that include multiple myeloma (MM), osteosarcoma, HCC, lung, and prostate cancers, neutralization or inhibition of DKK1 has been successful in inhibiting tumour growth in some cases or tumours burden in others [66,79,80,81].